Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma in Situ × Mastectomy, Subcutaneous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Carcinoma in Situ 1

Interventions

Magnetic Resonance Imaging 2 Interferon beta-1b 2 Electrocardiography 2 Diphenhydramine 2 Acetaminophen 2 valrubicin 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dodecyl maltoside 1 apaziquone 1 aldesleukin 1 Tomography, X-Ray Computed 1 Respiratory Function Tests 1 Proflavine 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Nicotine Replacement Therapy 1 Meperidine 1 Mastectomy, Subcutaneous 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Imiquimod 1 Hydroxyzine 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02311959 2024-12-24

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡